Circadia Health develops technology for post-acute care aimed at reducing patient rehospitalizations. Its core offering is contactless monitoring that uses radar technology to capture vital signs without touching the patient. The company's flagship product, the Circadia C200 device, is an FDA-cleared unit operating on this principle. At scale, the firm monitors over 30,000 patients daily.
The collected data feeds into a Clinical Intelligence Platform, which transforms patient information into actionable insights for healthcare providers. This platform, combined with care coordination services, forms a system designed to close the loop on patient care. The company reports a 30% reduction in rehospitalizations for facilities using its tools after a period of 12 months.
Technical work at Circadia Health spans several domains central to modern medical device development. These include AI, radar hardware and software engineering, predictive care modeling, and clinical vital sign capture. The company's products operate at the intersection of embedded systems, signal processing, and healthcare data analytics.
